GLPwatch
Trials (2036)
Page 5 of 34.
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
- Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
- Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
- Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
- The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
- Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
- Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
- Tirzepatide in PWS, HO and GNSO
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
- Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
- Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes
- PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
- INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
- Comparison of Two Liraglutide Formulations in Healthy Volunteers
- Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)
- Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
- Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
- A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
- A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
- The Impact of Food on Blood Sugar in People With Type 2 Diabetes
- "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
- Study on Lixisenatide and Counterregulation to Hypoglycemia
- A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
- XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
- Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
- A Study of LY3437943 in Healthy Participants With a High Body Mass Index
- Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
- Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis
- A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
- Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
- A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
- A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
- Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
- A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
- INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records
- Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
- A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
- A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
- Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
- Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
- A Study to Evaluate ALN-2232 in Participants With Obesity
- Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only